[Psoriasis].
Narita
Ichiei
I
Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences.
Gejyo
Fumitake
F
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003524:Cyclosporins / Q000008:administration & dosage; D003937:Diagnosis, Differential; D006801:Humans; D000069285:Infliximab; D008285:Major Histocompatibility Complex / Q000235:genetics; D008727:Methotrexate / Q000008:administration & dosage; D011701:PUVA Therapy; D010530:Peritoneal Dialysis; D011379:Prognosis; D011565:Psoriasis / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006435:Renal Dialysis; D018417:Th1 Cells / Q000276:immunology
D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D000069285:Infliximab; D008727:Methotrexate